Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer.
Dingxiao ZhangDeachan ParkYi ZhongYue LuKiera RycajShuai GongXin ChenXin LiuHsueh-Ping ChaoPamela WhitneyTammy Calhoun-DavisYoko TakataJianjun ShenVishwanath R IyerDean G TangPublished in: Nature communications (2016)
The prostate gland mainly contains basal and luminal cells constructed as a pseudostratified epithelium. Annotation of prostate epithelial transcriptomes provides a foundation for discoveries that can impact disease understanding and treatment. Here we describe a genome-wide transcriptome analysis of human benign prostatic basal and luminal epithelial populations using deep RNA sequencing. Through molecular and biological characterizations, we show that the differential gene-expression profiles account for their distinct functional properties. Strikingly, basal cells preferentially express gene categories associated with stem cells, neurogenesis and ribosomal RNA (rRNA) biogenesis. Consistent with this profile, basal cells functionally exhibit intrinsic stem-like and neurogenic properties with enhanced rRNA transcription activity. Of clinical relevance, the basal cell gene-expression profile is enriched in advanced, anaplastic, castration-resistant and metastatic prostate cancers. Therefore, we link the cell-type-specific gene signatures to aggressive subtypes of prostate cancer and identify gene signatures associated with adverse clinical features.
Keyphrases
- prostate cancer
- genome wide
- stem cells
- induced apoptosis
- radical prostatectomy
- gene expression
- dna methylation
- copy number
- single cell
- cell cycle arrest
- benign prostatic hyperplasia
- small cell lung cancer
- endoplasmic reticulum stress
- rna seq
- spinal cord injury
- signaling pathway
- genome wide identification
- squamous cell carcinoma
- cell therapy
- blood brain barrier
- young adults
- genetic diversity